Related Experiment Video
Updated: Apr 18, 2026

Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems
Published on: August 2, 2024
OPTN/SRTR 2013 Annual Data Report: heart
M Colvin-Adams1, J M Smith, B M Heubner
1Scientific Registry of Transplant Recipients, Minneapolis Medical Research Foundation, Minneapolis, MN; Department of Medicine, Division of Cardiology, University of Minnesota, Minneapolis, MN.
Insights
Heart transplant waiting lists are growing, with more adult candidates and increased use of life support. Despite longer waits, mortality has not risen, and pediatric survival rates are improving.
Area of Science:
- Cardiology
- Transplant Surgery
- Public Health
Background:
- The number of heart transplants is increasing, but the waitlist for adult candidates grew by 34.2% between 2003 and 2013.
- The heart transplant rate per active adult candidate declined from a peak of 149.0 in 2007 to 87.4 in 2013.
- While waiting times have increased, waitlist mortality has not shown a corresponding rise.
Purpose of the Study:
- To analyze trends in heart transplantation, including waitlist dynamics, patient acuity, and outcomes.
- To examine changes in the pediatric heart transplant landscape and recipient survival rates.
- To understand the financial coverage of heart transplant recipients by Medicare.
Main Methods:
- Analysis of national data on heart transplant candidates, procedures, and survival rates.
- Examination of trends in waitlist size, transplant rates, and patient acuity over a decade (2003-2013).
- Review of Medicare payment data for heart transplant recipients.
Main Results:
- The proportion of patients on life support before heart transplantation increased significantly from 53.4% in 2008 to 65.8% in 2013.
- Medical urgency categories have become less distinct, with a majority of patients now in higher acuity levels.
- Annual pediatric heart transplants increased from 293 in 2003 to 411 in 2013, with improving 5-year survival rates (70%-80%) for transplants performed between 2001-2008.
Conclusions:
- Despite increased waiting times and higher patient acuity, heart transplant outcomes remain stable or are improving, particularly for pediatric recipients.
- The evolving landscape of heart transplantation necessitates continuous monitoring of waitlist management and patient outcomes.
- Medicare plays a substantial role in covering the costs associated with heart transplantation.
Abstract:
The number of heart transplants performed annually continues to increase gradually, and the number of adult candidates on the waiting list increased by 34.2% from 2003 to 2013. The heart transplant rate among active adult candidates peaked at 149.0 per 100 waitlist years in 2007 and has been declining since then; in 2013, the rate was 87.4 heart transplants per 100 active waitlist years. Increased waiting times do not appear to be correlated with an overall increase in waitlist mortality. Since 2008, the proportion of patients on life support before transplant increased from 53.4% to 65.8% in 2013. Medical urgency categories have become less distinct, with most patients listed in higher urgency categories. Approximately 500 pediatric candidates are added to the waiting list each year; the number of pediatric transplants performed each year increased from 293 in 2003 to 411 in 2013. Patient survival among pediatric recipients continues to improve; 5-year patient survival for transplants performed from 2001 through 2008 was 70% to 80%. Medicare paid for some or all of the care for 42.2% of all heart transplant recipients in 2012.
More Related Videos
08:15Innovative Strategies for Organ Preservation in Heart Transplantation: Uniform Cooling Preservation and Ex-situ Normothermic Perfusion
Published on: November 28, 2025
07:08A High-Fidelity Porcine Model of Orthotopic Heart Transplantation Following Donation after Circulatory Death
Published on: June 6, 2025
Related Concept Videos
Kidney Transplant I: Introduction
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...